Safety and Efficacy Study of the First Domestically Produced FireMagic™ PreciSense™ 3D Microelectrode Ablation Catheter Therapy for Rapid Arrhythmia With Tissue Temperature Measurement Function

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorShanghai MicroPort EP MedTech Co., Ltd.

About this trial

This project aims to evaluate the safety, efficacy, and cost-effectiveness of using FireMagic™ PreciSense™ 3D Microelectrode Ablation Catheter to treat rapid arrhythmias.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Confirmed diagnosis of supraventricular tachycardia or atrial fibrillation requiring catheter radiofrequency ablation surgery;

Signed informed consent form approved by the ethics committee;

Willingness to undergo follow-up and evaluation as required by the protocol.

Disqualifiers

Left atrial size ≥50 mm, left ventricular ejection fraction ≤40%;

Left atrial thrombus;

History of atrial septal repair or atrial myxoma;

History of cerebrovascular disease within the past 3 months (including stroke or transient ischaemic attack);

Trial design

Design model

Single group

Treatments tested in this trial

  • FireMagic™ PreciSense™ 3D Microelectrode Ablation Catheter、EasyStars™ High Density Mapping Catheter、Columbus™ 3D EP Navigation System

    Device

    All patients were treated withFireMagic™ PreciSense™ 3D Microelectrode Ablation Catheter、EasyStars™ High Density Mapping Catheter and Columbus™ 3D EP Navigation System for rapid arrhythmia.

Treatment groups

300 Participants
are divided into 1 treatment group
Group A: Rapid Arrhythmia(Paroxysmal supraventricular tachycardia and Atrial Fibrillation)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

major evaluation indicators--Efficacy indicators

Immediate success rate of the investigational device in treating rapid arrhythmias;

Time frame
On the day of the surgery
2

Major evaluation indicators--Monitoring methods

Radiofrequency ablation treatment of rapid arrhythmias (such as supraventricular tachycardia and atrial fibrillation) using the trial device, with immediate ablation success determined based on the operator's professional experience combined with real-time intracardiac electrocardiogram display, followed by statistical analysis;

Time frame
On the day of the surgery
3

Major evaluation indicators--Safety indicators:Perioperative study of the incidence of adverse events related to medical devices

Statistics on the incidence of adverse events related to surgical instruments during the perioperative period

Time frame
perioperative period

Secondary outcomes

1

Changes in the surface temperature of the ablated tissue

extract multiple surface temperature data through tissue temperature measurement catheter microelectrodes and perform statistical analysis;

Time frame
During surgery
2

Changes in ablation point impedance

evaluate secondary indicators of tissue temperature measurement catheters, observe the impedance display of the radiofrequency ablation device, and record whether the impedance decreases during ablation

Time frame
During surgery

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: